Association between the JNC 7 classification of the stages of systolic hypertension and inflammatory cardiovascular risk factors

Korean Circulation Journal

Volumn 37, Issue 12, 2007, Pages 623-629

  Chan, Seok Park ^a   Kim, Hee Yeol ^a,b   Park, Hun Jun ^a   Jang, Sung Won ^a   Ihm, Sang Hyun ^a   Lee, Jong Min ^a   Yoo, Ki Dong ^a   Jeon, Doo Soo ^a   Baek, Sang Hong ^a   Youn, Ho Joong ^a   Seung, Ki Bae ^a   Kim, Jae Hyung ^a   Choi, Kyu Bo ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Hypertension; Inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE MARKER; DOSE RESPONSE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 38949165422     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2007.37.12.623     Document Type: Article

References (30)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
2. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-7.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
4. Ridker PM. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8.
5. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42.
6. Weissberg PL, Bennett MR. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 1928-9.
7. Lee S, Kim W, Hwang SH, et al. The relationship of inflammatory reaction with the mortality of type B acute aortic syndrome. Korean Circ J 2006; 36: 387-92.
8. Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-51.
9. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857-61.
10. Sung KC, Suh JY, Kim BS, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429-33.
11. Bautista LE, Atwood JE, O'Malley PG, Taylor AJ. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis 2004; 15: 331-6.
12. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, Md: US Dept of Health and Human Services; 1994. Publication No.: (PHS) 94-1308.
13. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
14. Gunter EW, Lewis BG, Konchikowski. Laboratory precedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-94. Hyattsville, Md: National Center for Health Statistics; 1996.
15. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203-14.
16. Cho DK, Kwon SU, Kim SW, et al. Risk factors and predictors for the progression of carotid atherosclerotic stenosis in Korean adults. Korean Circ J 2005; 35: 834-40.
17. Mora S, Rifai N, Buring JE, Ridker PM. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation 2006; 114: 381-7.
18. Engstrom G, Janzon L, Berglund G, et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002; 22: 2054-8.
19. Hwang ST, Kim BS, Hwang SJ, et al. Associations between white blood cell count and features of the metabolic syndrome. Korean Circ J 2004; 34: 280-7.
20. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA 1992; 267: 1253-6.
21. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172: 1-6.
22. Shankar A, Klein BE, Klein R. Relationship between white cell count and incident hypertension. Am J Hypertens 2004; 17: 233-9.
23. Han SW, Ryu KH, Kwon YB, et al. Serum total homocysteine as a risk factor for patients with coronary artery disease. Korean Circ J 1998; 28: 1953-63.
24. Davey Smith G, Lawlor DA, Harbord R, et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005; 25: 1051-6.
25. Marques-Vidal P, Cambou JP, Bongard V, Ruidavets JB, Ferrieres J. Systolic and diastolic hypertension: no relationship with lipid and inflammatory markers in Haute-Garonne, France. Am J Hypertens 2003; 16: 681-4.
26. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cyto kines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-8.
27. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 2003; 122: 135-41.
28. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9: 175-80.
29. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-72.
30. Kotis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997; 278: 212-6.